NanoString Technologies, Inc. Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET

Company Participants

Doug Farrell - VP of IR & Corporate Communications

Brad Gray - CEO, President & Director

Tom Bailey - CFO

Conference Call Participants

Daniel Brennan - Cowen

Dan Arias - Stifel

Julia Qin - JPMorgan

Kyle Mikson - Canaccord Genuity

Catherine Schulte - Robert W. Baird

Tejas Savant - Morgan Stanley

Operator

Hello. And thank you for attending today's NanoString First Quarter 2022 Operating Results Conference Call. My name is Selena, and I will be your moderator. All lines will be muted during the presentation portion of the call with an opportunity for questions-and-answers at the end. [Operator Instructions].

I would now like to pass the conference over to our host, Doug Farrell, Investor Relations. Please go ahead.

Doug Farrell

Thank you, operator. Good afternoon, everyone. Joining me on the call today is our President and CEO, Brad Gray; as well as our CFO, Tom Bailey. Earlier today, we released our financial results for the first quarter of 2022.

During this call, we may make statements that are forward-looking, including statements about financial projections and the impact of COVID-19, future business growth, trends and related factors, prospects for expanding and penetrating our addressable markets, our strategic focus and objectives and the development status and anticipated success of recently planned product offerings.

Forward-looking statements are subject to risks and uncertainties, many of which are beyond our control, including the risks and uncertainties described in our SEC filings. Our results may differ materially, and we undertake no obligation to update these forward-looking statements.

Later in the call, Tom will be discussing our financial results and 2022 guidance. We are prepared to supplement the GAAP financial measures, selected non-GAAP adjusted measures in calculation of which are detailed in our press release. Throughout the call, all financial missions will be GAAP, unless otherwise noted. You can also find reconciliations of GAAP to non-GAAP measures as well as the description, limitations and rationale for using each measure in today's press release.

With any analysts or investors in building their models, we have posted exhibits under the Financial Information tab of our Investor Relations page that include presentation of our non-GAAP or adjusted measures and other selected financial data. I'd like to remind everyone that we'll be presenting at UBS Healthcare Conference in two weeks. We look forward to having the opportunity to speak with many of you there.